ClassID:

96428

C07H19/11 - CPC Classification

Classification description:

Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides ; Anhydro-derivatives thereof sharing nitrogen; Heterocyclic radicals containing only nitrogen atoms as ring hetero atom; Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids containing cyclic phosphate

Recent Application in this class:
#1
20250188111
2025-06-12

CYCLIC PHOSPHORAMIDATE COMPOUNDS

#2
20240294565
2024-09-05

UNNATURAL CONFIGURATION NUCLEOTIDE PRODRUG COMPOUNDS

#3
20230293566
2023-09-21

N4-Hydroxycytidine and Derivatives and Anti-Viral Uses Related Thereto

#4
20230242567
2023-08-03

Chiral phosphoramidite auxiliaries and methods of their use

#5
20230062181
2023-03-02

ALKYNE CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO

#6
20220127301
2022-04-28

ASYMMETRIC AUXILIARY GROUP

#7
20210205347
2021-07-08

Compounds, compositions, and methods for the treatment of disease

#8
20210060050
2021-03-04

N4-hydroxycytidine and derivatives and anti-viral uses related thereto

#9
20200385420
2020-12-10

Asymmetric auxiliary group

#10
20200317713
2020-10-08

Liver specific delivery-based entecavir prodrug, nucleoside cyclic phosphate compound, and application thereof

#11
20200317712
2020-10-08

Liver specific delivery-based gemcitabine prodrug nucleoside cyclic phosphate compound, and application thereof

#12
20200317711
2020-10-08

Cytarabine prodrug nucleoside cyclic phosphate compound based on liverspecific delivery and use

#13
20200140476
2020-05-07

Chiral phosphoramidite auxiliaries and methods of their use

#14
20200109161
2020-04-09

Uracyl spirooxetane nucleosides

#15
20200048299
2020-02-13

Liver-specific delivery-based anti-hepatitis C prodrug nucleoside cyclo-phosphate compound and uses thereof

#16
20190241604
2019-08-08

Uracyl spirooxetane nucleosides

#17
20190233463
2019-08-01

Cyclic phosphate substituted nucleoside compounds and methods of use thereof for the treatment of viral diseases

#18
20190177357
2019-06-13

Asymmetric auxiliary group

#19
20190144484
2019-05-16

Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto

#20
20190100551
2019-04-04

5-fluorouridine monophosphate cyclic triester compounds

#21
20190092804
2019-03-28

Uracyl spirooxetane nucleosides

#22
20190085010
2019-03-21

HCV POLYMERASE INHIBITORS

#23
20190022116
2019-01-24

N4-Hydroxycytidine and Derivatives and Anti-Viral Uses Related Thereto

#24
20180327441
2018-11-15

URACYL SPIROOXETANE NUCLEOSIDES

#25
20180208621
2018-07-26

Nucleotides for the treatment of cancer

#26
20180155385
2018-06-07

Nucleotides for the treatment of cancer

#27
20180099990
2018-04-12

Uracyl spirooxetane nucleosides

#28
20180079774
2018-03-22

SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

#29
20180044369
2018-02-15

Substituted nucleosides, nucleotides and analogs thereof

#30
20170334942
2017-11-23

Derivatives of uridine 5′-cyclophosphate useful to treat hepatitis C viral infections

#31
20170165287
2017-06-15

CRYSTAL FORM OF A NUCLEOSIDE INHIBITOR OF HCV

#32
20170145045
2017-05-25

Uracyl spirooxetane nucleosides

#33
20170088573
2017-03-30

Gemcitabine analogs

#34
20170044205
2017-02-16

3′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCV

#35
20170029445
2017-02-02

Asymmetric auxiliary group

#36
20160360754
2016-12-15

Herbicidal composition comprising flazasulfuron and an inhibitor of protoporphyrinogen oxidase

#37
20160347783
2016-12-01

Derivatives of uridine 5′-cyclophosphate useful to treat hepatitis C viral infections

#38
20160340380
2016-11-24

HCV polymerase inhibitors

#39
20160264611
2016-09-15

4′-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus RNA replication

#40
20160176911
2016-06-23

Substituted nucleosides, nucleotides and analogs thereof

#41
20160122380
2016-05-05

Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases

#42
20160010150
2016-01-14

Single molecule sequencing with two distinct chemistry steps

#43
20150299243
2015-10-22

2′-alkynyl substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases

#44
20150266918
2015-09-24

Bridged-cyclo-ProTides as prodrugs of therapeutic nucleosides and nucleotides

#45
20150197540
2015-07-16

Asymmetric auxiliary group

#46
20150183819
2015-07-02

Azido nucleosides and nucleotide analogs

#47
20150141365
2015-05-21

Uracyl spirooxetane nucleosides

#48
20150105341
2015-04-16

Substituted nucleosides, nucleotides and analogs thereof

#49
20150080457
2015-03-19

5′ phosphate mimics

#50
20150011497
2015-01-08

Substituted nucleosides, nucleotides and analogs thereof

#51
20140341847
2014-11-20

4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication

#52
20140303108
2014-10-09

Cyclic nucleotide analogs

#53
20140248242
2014-09-04

Thiophosphate nucleosides for the treatment of HCV

#54
20140235566
2014-08-21

Pyrimidine nucleosides and their monophosphate prodrugs for the treatment of viral infections and cancer

#55
20140219958
2014-08-07

5, 6-Duridine nucleoside/tide derivatives

#56
20140206640
2014-07-24

2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases

#57
20140161770
2014-06-12

2′-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseases

#58
20140154211
2014-06-05

2′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases

#59
20140127680
2014-05-08

Single molecule sequencing with two distinct chemistry steps

#60
20140121108
2014-05-01

Herbicidal composition comprising flazasulfuron and an inhibitor of protoporphyrinogen oxidase

#61
20140112887
2014-04-24

2′,4′-bridged nucleosides for HCV infection

#62
20140099283
2014-04-10

2′-chloro nucleoside analogs for HCV infection

#63
20130315867
2013-11-28

3′,5′-cyclic phosphate prodrugs for HCV infection

#64
20130315866
2013-11-28

3′,5′-cyclic phosphoramidate prodrugs for HCV infection

#65
20120263678
2012-10-18

1′-substituted pyrimidine N-nucleoside analogs for antiviral treatment

#66
20120165286
2012-06-28

Cyclic nucleotide analogs

#67
20120157511
2012-06-21

5′ phosphate mimics

#68
20120116067
2012-05-10

Method for the solid phase-based production of phosphate-bridged nucleoside conjugates

#69
20120070415
2012-03-22

Azido nucleosides and nucleotide analogs

#70
20110212437
2011-09-01

Single molecule sequencing with two distinct chemistry steps

#71
20110009606
2011-01-13

Synthesis of 2′,3′— and 3′,5′—cyclic phosphate mono-and oligonucleotides

#72
20070032448
2007-02-08

Sugar modified nucleosides as viral replication inhibitors